Impact of the COVID-19 pandemic on gastrointestinal endoscopy in the Netherlands: analysis of a prospective endoscopy database.


Journal

Endoscopy
ISSN: 1438-8812
Titre abrégé: Endoscopy
Pays: Germany
ID NLM: 0215166

Informations de publication

Date de publication:
Feb 2021
Historique:
pubmed: 21 10 2020
medline: 4 2 2021
entrez: 20 10 2020
Statut: ppublish

Résumé

 COVID-19 has dramatically affected gastrointestinal endoscopy practice. We aimed to investigate its impact on procedure types, indications, and findings.  We retrospectively analyzed endoscopies performed in 15 Dutch hospitals by comparing periods 15 March to 25 June of 2019 and 2020 using the prospective Trans.IT database.  During lockdown in 2020, 9776 patients underwent endoscopy compared with 19 296 in 2019. Gastroscopies decreased by 57 % (from 7846 to 4467) and colonoscopies by 45 % (from 12219 to 5609), whereas endoscopic retrograde cholangiopancreatography volumes remained comparable (from 578 to 522). Although endoscopy results indicative of cancer decreased (from 524 to 340), the likelihood of detecting cancer during endoscopy increased (2.7 % [95 % confidence interval (CI) 2.5 - 3.0] in 2019 versus 3.5 % [95 %CI 3.1 - 3.9] in 2020;  Fewer endoscopies were performed during the COVID-19 lockdown, leading to a significant reduction in the absolute detection of cancer. Endoscopies increased rapidly after lockdown, except for colorectal cancer screening.

Sections du résumé

BACKGROUND BACKGROUND
 COVID-19 has dramatically affected gastrointestinal endoscopy practice. We aimed to investigate its impact on procedure types, indications, and findings.
METHODS METHODS
 We retrospectively analyzed endoscopies performed in 15 Dutch hospitals by comparing periods 15 March to 25 June of 2019 and 2020 using the prospective Trans.IT database.
RESULTS RESULTS
 During lockdown in 2020, 9776 patients underwent endoscopy compared with 19 296 in 2019. Gastroscopies decreased by 57 % (from 7846 to 4467) and colonoscopies by 45 % (from 12219 to 5609), whereas endoscopic retrograde cholangiopancreatography volumes remained comparable (from 578 to 522). Although endoscopy results indicative of cancer decreased (from 524 to 340), the likelihood of detecting cancer during endoscopy increased (2.7 % [95 % confidence interval (CI) 2.5 - 3.0] in 2019 versus 3.5 % [95 %CI 3.1 - 3.9] in 2020;
CONCLUSIONS CONCLUSIONS
 Fewer endoscopies were performed during the COVID-19 lockdown, leading to a significant reduction in the absolute detection of cancer. Endoscopies increased rapidly after lockdown, except for colorectal cancer screening.

Identifiants

pubmed: 33080630
doi: 10.1055/a-1272-3788
pmc: PMC7869035
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

166-170

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : ErratumIn

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

Prof. Bruno is a consultant for and has received support for industry- and investigator-initiated studies from Boston Scientific and Cook Medical. He has also received support for investigator-initiated studies from Pentax Medical, Mylan, and ChiRoStim. Dr. Ouwendijk has received research grants from Janssen Netherlands, Olympus, and the Coolsingel Foundation. Prof. Siersema has received research grants from Norgine, Pentax, Microtech, Yakult, and Motus GI (ongoing), and is an advisory board member for Motus GI. All other authors declare that they have no conflicts of interest.

Références

Endoscopy. 2020 Jun;52(6):483-490
pubmed: 32303090
Ann Oncol. 2020 Aug;31(8):1065-1074
pubmed: 32442581
Dig Dis Sci. 2007 Apr;52(4):1004-8
pubmed: 17380400
Endoscopy. 2020 Nov;52(11):1036-1038
pubmed: 32408356
Clin Gastroenterol Hepatol. 2020 Sep;18(10):2287-2294.e1
pubmed: 32447019
Endoscopy. 2020 Apr;52(4):312-314
pubmed: 32212122
Scand J Gastroenterol. 2010 Sep;45(9):1121-6
pubmed: 20504245
Gastroenterology. 2020 Aug;159(2):772-774.e13
pubmed: 32376410
Gut. 2015 Oct;64(10):1637-49
pubmed: 26041752
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Eur J Intern Med. 2007 Jul;18(4):321-5
pubmed: 17574108
Neth J Med. 2006 Mar;64(3):78-83
pubmed: 16547359

Auteurs

Marten A Lantinga (MA)

Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.

Felix Theunissen (F)

Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlands.

Pieter C J Ter Borg (PCJ)

Department of Gastroenterology and Hepatology, Ikazia Ziekenhuis, Rotterdam, The Netherlands.

Marco J Bruno (MJ)

Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlands.

Rob J T Ouwendijk (RJT)

Department of Gastroenterology and Hepatology, Bravis Ziekenhuis, Roosendaal, The Netherlands.

Peter D Siersema (PD)

Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH